Imperial spin-out launches robotic COVID-19 PCR-based tests
Heptares enters drug collaboration with Imperial
Abzena develops new facilities in Cambridge, UK and San Diego
Domainex expands partnership with ICL to reduce heart muscle damage during heart attacks
Study calls for strategy to fight multidrug-resistant TB in migrants
Global research network hunts the missing link between genetics and environmental factors to unlock the secrets of global diseases
Owlstone Medical and Imperial College collaborate to study underlying causes of asthma exacerbations
Superbug infections tracked across Europe
Heptares announces ORBIT initiative to broaden application of G protein-coupled receptors in drug development
Consortium of UK Universities and global pharma companies launch £40m innovation fund
Wellcome Trust grants Mucosis €3.7m for clinical trials in partnership with Imperial College
Apta receives H2020 EU grant to develop next-generation antibiotics with Seligo technology
Prototype nanoneedles generate new blood vessels in mice
Medical breakthroughs on the horizon with a UK research boost of £32m
Imperial College London invests in new research facility at Babraham Research Campus
